Chile vs Sub-Saharan Africa: Proportion of the target population who received the final dose of
Chile
87.0%
in 2024
Sub-Saharan Africa
44.0%
in 2024
Chile rank
16th
Sub-Saharan Africa rank
17th
Proportion of the target population who received the final dose of over time
- Chile
- Sub-Saharan Africa
How they compare
Chile currently reports 87.0% against 44.0% in Sub-Saharan Africa, a difference of 43.0%.
That makes Chile's figure about 2.0 times Sub-Saharan Africa's.
Across all 10 years both countries report, Chile has been ahead every year.
Chile ranks 16th and Sub-Saharan Africa ranks 17th of 107 countries.
Chile has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Chile | Sub-Saharan Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 77.8% | 6.4% | 71.4% | Chile |
| 2020s | 74.6% | 23.8% | 50.8% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Chile or Sub-Saharan Africa?
- Chile, at 87.0% against 44.0% in Sub-Saharan Africa as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Chile and Sub-Saharan Africa?
- 43.0%, with Chile ahead.
- How many years of comparable data are there for Chile and Sub-Saharan Africa?
- 10 years are reported by both, from 2015 to 2024.
- How do Chile and Sub-Saharan Africa rank globally for proportion of the target population who received the final dose of?
- Chile ranks 16th and Sub-Saharan Africa ranks 17th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.